|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine, University of Toronto, Division of Respirology, St. Michaels Hospital, Toronto, Canada.
Correspondence to: Victor Hoffstein, MD, FCCP, St. Michaels Hospital, 30 Bond St, Suite 6015, Toronto, Ontario, Canada M5B 1W8; e-mail: victor.hoffstein{at}utoronto.ca
| Abstract |
|---|
|
|
|---|
Design: Cross-sectional study utilizing a sleep clinic patient database.
Setting: University hospital.
Patients: A total of 1,315 women, classified into premenopausal and postmenopausal groups based on age (< 45 years and > 55 years, respectively).
Measurements: Anthropometric measurements included height, weight, and neck circumference. Sleep measurements included full nocturnal polysomnography. Sleep apnea was defined as an apnea-hypopnea index (AHI) > 10/h.
Results: There were 797
premenopausal and 518 postmenopausal women. The latter group was more
obese (mean ± SE BMI, 32.2 ± 0.4 kg/m2 vs
30.2 ± 0.4 kg/m2; p < 0.0001) and had larger neck
circumference (37.1 ± 0.2 cm vs 35.8 ± 0.2 cm; p < 0.0001).
The prevalence of sleep apnea was greater in postmenopausal women than
premenopausal women (47% vs 21%;
2 < 0.0001). There
were proportionately more postmenopausal than premenopausal women in
all ranges of apnea severity (AHI, 10 to 30/h, 30 to 50/h, and
> 50/h). Postmenopausal women had a significantly higher mean AHI
compared to premenopausal women (17.0 ± 0.9/h vs 8.7 ± 0.6/h;
p < 0.0001); this significant difference persisted even after
adjusting for BMI and neck circumference.
Conclusion: There may be functional, rather than anatomic, differences in the upper airway between premenopausal and postmenopausal women, which may account for the observed differences in apnea prevalence and severity.
Key Words: menopause sleep apnea women
| Introduction |
|---|
|
|
|---|
Since the effect of menopause on sleep is still a matter of controversy, it is not surprising that the potential mechanisms that may account for possible differences are highly speculative. Some authors6 7 8 9 have suggested that estrogen and progesterone exert a protective effect on the upper airway, preventing premenopausal women from developing sleep apnea. Carskadon et al10 found that differences in body fat distribution explain the increase in sleep apnea seen in postmenopausal women. However, all of these studies are limited by small patient numbers. Consequently, the purpose of this study was to compare the prevalence and severity of sleep apnea in premenopausal and postmenopausal women in a large clinic population, after adjusting for such common confounders as body mass index (BMI) and neck circumference.
| Materials and Methods |
|---|
|
|
|---|
Overnight Polysomnography
Overnight polysomnography was performed in all patients and
included monitoring of EEG, electro-oculograms, submental and tibial
electromyograms, ECG, oxygen saturation using pulse oximeter (Biox
3700/3740; Ohmeda; Boulder, CO), respiratory effort using inductance
plethysmography (Respitrace; Ambulatory Monitoring; Ardsley, NY), and
airflow. Two surrogate measures of airflow were used: either (1)
expired CO2 at the nose and mouth through
cannulas adapted for this purpose and attached to a
CO2 analyzer (CD 102 Normocap; Datex; Helsinki,
Finland), or (2) monitoring of oronasal temperature using
thermistors. All variables were recorded either on a polygraph (models
78D or 78E; Grass Instruments; Quincy, MA) at a paper speed of 10 mm/s,
or using a computerized acquisition system (Sandman; Mallinckrodt
Nellcor Puritan Bennett; Melville, Ottawa, Ontario).
Polysomnograms were scored manually. Sleep stage and arousals were determined according to established criteria.11 An obstructive apnea was defined as a cessation of airflow for > 10 s despite persistent respiratory effort. Hypopnea was defined as a reduction in the amplitude of respiratory effort by at least 50% of the baseline sleeping level, for > 10 s. The apnea-hypopnea index (AHI) was defined as the number of apneas and hypopneas per hour of sleep.
Menopausal Status
We defined women as being premenopausal if they were < 45
years of age and postmenopausal if they were > 55 years of age. This
was based on evidence by McKinlay et al12
that the median
age of onset of the perimenopausal transition is 47.5 years, and that
the median age of menopause is 51.3 years. Women were excluded if they
were between 45 years and 55 years of age, were receiving the birth
control pill or hormone replacement therapy, and if they had a history
of premature ovarian failure, polycystic ovaries, or iatrogenic
menopause.
Statistical Analysis
Data are reported as the mean ± SE. The prevalence of sleep
apnea (defined as AHI > 10) in premenopausal and postmenopausal women
was compared using
2 tests. The severity of
sleep apnea was compared using unpaired t test. However, AHI
is generally correlated with BMI and neck circumference. These two
variables may be significantly different in the premenopausal and
postmenopausal groups. Consequently, in order to correct for this
mismatch, we performed analysis of covariance, with BMI and neck
circumference as the covariate variables. All statistical analyses were
carried out using statistical software (SAS Statistical Software,
Version 7; SAS Institute; Cary, NC). The level of significance was
assumed to be equal to 0.05.
| Results |
|---|
|
|
|---|
|
2 < 0.0001); with a more strict definition
of sleep apnea based on AHI > 20/h, the prevalence among
postmenopausal women dropped to 28% vs 10% in premenopausal women
(
2 < 0.0001).
Furthermore, we found proportionally more postmenopausal than
premenopausal women in all ranges of apnea severity (AHI > 10/h but
30/h; AHI >30/h but
50/h, and AHI > 50/h). Among nonapneic
women (AHI
10), the opposite was true: more premenopausal than
postmenopausal women (Fig 1
).
|
The relationship between AHI and BMI (Fig 2 ) was more linear in postmenopausal women than in premenopausal women; the latter showed more rapid increase in AHI with BMI in the most obese range. However, the relationship between AHI and neck circumference (Fig 2) was similar in the two groups.
|
| Discussion |
|---|
|
|
|---|
The most serious limitation of our study is our definition of menopause. Ideally, either serum hormone levels or the date of the last menstrual period are necessary to determine menopausal status. Unfortunately, we did not have either to help us distinguish premenopausal from postmenopausal women. Instead, we used age (< 45 years and > 55 years) as a surrogate marker of menopausal status. The support for this approach comes from the Massachusetts Womens Health Study.12 In this large, prospective cohort study of 2,565 middle-age women, the median age of menopause was 51.3 years, and the median age of onset of the transition to menopause was 47.5 years.
Nevertheless, it is theoretically possible, although unlikely, that some women < 45 years old are in fact postmenopausal, while others > 55 years are premenopausal. This would obviously alter the composition of our assumed premenopausal and postmenopausal groups, conceivably affecting our results and conclusions. We attempted to estimate the error caused by this possible misclassification by performing the following calculation. We assumed the "worse case scenario," ie, 5% of women 40 to 45 years old with the lowest AHI are postmenopausal, and 5% of women 55 to 60 years old with the highest AHI are premenopausal. We then recalculated the prevalence and severity of sleep apnea for the two groups. Even with this assumption, we still found that the prevalence of sleep apnea in the premenopausal group was significantly lower than in the postmenopausal group (19% vs 53%). In addition, premenopausal women still had significantly lower AHI than postmenopausal women (10.3 ± 0.7/h vs 14.3 ± 0.8/h, respectively).
Another important limitation of the analysis is that due to the definition for menopausal status, the role of aging cannot be addressed. Consequently, we cannot be sure that the differences in AHI between premenopausal and postmenopausal women are due to menopause or age. An indirect way to assess the effect of age on AHI is to determine whether prevalence and severity of sleep apnea vary by age within each menopausal group. We therefore classified all premenopausal women into three age groups (< 30 years, 30 to 40 years, and > 40 years). Similarly, all postmenopausal women were classified into three age groups (< 60 years, 60 to 70 years, and > 70 years). We used analysis of variance to compare AHI between the age groups (separately for premenopausal and postmenopausal women), after adjusting for BMI and neck circumference. We found no difference in AHI as a function of age group.
Clearly, we do not advocate using age as a substitute measure to
determine the menopausal status, but we believe that in our patient
population, age-related differences in sleep apnea prevalence and
severity relatively accurately reflect the differences due to
menopausal status. Another potential confounding factor affecting our
results relates to a possible referral bias. It is conceivable that
most of the premenopausal women were referred because of a
nonrespiratory sleep disorder, whereas most of the postmenopausal women
were referred because of suspicion of sleep apnea. If this were the
case, it would not be surprising that premenopausal women have a lower
prevalence and less severe sleep apnea than postmenopausal women. To
deal with this possibility, we examined the chief complaints of all
patients. Those who presented with the chief complaint suggestive of
obstructive sleep apnea (OSA; ie, snoring, gasping, choking,
observed episodes of cessation of breathing, and excessive daytime
tiredness, sleepiness, or fatigue) were termed "OSA symptoms +,"
and all others were termed "OSA symptoms -." We found that 67%
of premenopausal women presented with symptoms of OSA, vs 69% of
postmenopausal women (
2, 0.52). This indicates
that referral bias in unlikely to account for our findings.
The effect of menopause on sleep apnea prevalence and severity has been a matter of debate in the literature. For example, contrary to our results, Millman et al5 found no significant differences in AHI, BMI, or anthropometric measurements between premenopausal and postmenopausal women. However, the study included only 12 premenopausal women and 13 postmenopausal women. Ware et al4 recently studied the influence of age and gender on the duration and frequency of apnea events. Although the authors4 found no difference in the apnea index between young (ages 18 to 39 years) and middle-aged (ages 40 to 59 years) women, it doubled when comparing middle-aged with older (ages 60 to 88 years) women. A relatively high prevalence of sleep apnea among postmenopausal women has been observed in the general population as well as in the clinic population. For example, Zamarron et al13 found the prevalence of sleep-disordered breathing (AHI > 5/h) in a general population of women aged 50 to 70 years to be 30%.
We controlled for BMI and neck circumference when comparing the severity of apnea in premenopausal and postmenopausal women. This was done because of overwhelming evidence indicating that these two variables constitute the most important determinants of apnea severity. Several previous investigations14 15 have pointed out the importance of regional (ie, upper airway) and generalized obesity in affecting the severity of sleep apnea. Much of the relationship between obesity and sleep apnea is explained by neck size, upper-airway compliance, and fat content in the neck. When patients are matched for BMI, apneic patients have larger neck circumferences compared with nonapneic patients.16 Obese patients with larger necks tend to have a more collapsible velopharynx during wakefulness, predisposing them to upper-airway obstruction during sleep.17 A study18 using CT to assess visceral fat accumulation found that patients with increased visceral fat also tended to have larger fluctuations in upper-airway size between inspiration and expiration. MRI studies19 20 have shown that the thickness of the lateral pharyngeal walls in the neck accounts for most of the airway narrowing found in apneic subjects. Even nonobese subjects with sleep apnea have larger neck volumes and fat content than those who are normal or only have simple snoring.21
Our results show that BMI and neck circumference status do not entirely explain the differences in apnea prevalence and severity between premenopausal and postmenopausal women. Clearly, there must be other factors that influence the observed differences. Some of these factors have been pointed out by other investigators6 7 8 9 ; one common hypothesis is that differences in estrogen and progesterone levels may explain the differences in apnea.
There are five studies2 6 7 8 9 of postmenopausal women receiving treatment with female sex hormones, in the hope of abolishing sleep apnea. However, the results are inconsistent. In two of the studies,4 5 administration of estradiol, estrogen, or progestin to 16 postmenopausal women resulted in a reduction of time awake, an increase in the proportion of rapid eye movement sleep, a reduction in AHI, and an improvement in oxygen saturation. This improvement may have been due to increased upper-airway dilator muscle activity mediated by estrogen and progesterone, as supported in a study by Popovic and White.8 However, Block et al2 and Cistulli et al9 administered hormone replacement therapy to a group of postmenopausal women and found no reduction in sleep-disordered breathing events. All of these studies suffer from small sample size. Only one study2 had a placebo-controlled group. Carskadon et al10 hypothesized than nasal obstruction, which is a risk factor for snoring and apnea, may be influenced by the menopausal status. However, although application of nasal occlusion to premenopausal and postmenopausal women did increase AHI, it was independent of the menopausal status.
In summary, using the largest sample of a female clinic population to date, we found that sleep apnea is more prevalent and more severe in postmenopausal women compared to the premenopausal women. However, menopause status, BMI, and neck circumference account for < 30% of the variability in sleep apnea. It is therefore possible, although it remains to be proven, that hormonal replacement may not fully abolish sleep apnea in postmenopausal women. Further investigations are required to elucidate the factors that account for the differences in apnea activity between premenopausal and postmenopausal women.
| Footnotes |
|---|
Received for publication September 1, 2000. Accepted for publication February 22, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Eikermann, A. S. Jordan, N. L. Chamberlin, S. Gautam, A. Wellman, Y.-L. Lo, D. P. White, and A. Malhotra The Influence of Aging on Pharyngeal Collapsibility During Sleep Chest, June 1, 2007; 131(6): 1702 - 1709. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. M. Ip, B. Lam, L. C. H. Tang, I. J. Lauder, T. Y. Ip, and W. K. Lam A Community Study of Sleep-Disordered Breathing in Middle-Aged Chinese Women in Hong Kong: Prevalence and Gender Differences Chest, January 1, 2004; 125(1): 127 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J R Stradling and R J O Davies Sleep {middle dot} 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history Thorax, January 1, 2004; 59(1): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saaresranta and O. Polo Sleep-disordered breathing and hormones Eur. Respir. J., July 1, 2003; 22(1): 161 - 172. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |